安全針の世界市場

【英語タイトル】Safety Needles Market: North America to Dominate the Global Market Through 2027: Global Industry Analysis and Opportunity Assessment 2017-2027

Future Market Insightsが出版した調査資料(DATA70609028)・商品コード:DATA70609028
・発行会社(調査会社):Future Market Insights
・発行日:2017年4月
・ページ数:215
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:部品
◆販売価格オプション(消費税別)
Individual PriceUSD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Corporate PriceUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

North America is the largest market while Asia Pacific Excluding Japan is the fastest growing market in the global safety needles market
The global safety needles market is estimated to be valued at nearly US$ 4,000 Mn in 2017 and is anticipated to touch almost US$ 8,000 Mn by 2027 end, registering a CAGR of 6.9 % over the forecast period. North America is the largest regional market, which is estimated to cross US$ 1,200 Mn, or 31.1% share of the total market share in 2017 and is estimated to reach a market valuation in excess of US$ 2,500 Mn by 2027, registering a CAGR of 7.3% over the forecast period. APEJ is the fastest growing market, which is expected to grow from nearly US$ 540 Mn in 2017 to over US$ 1,100 Mn by 2027.

As the global safety needles market is replete with continuous new innovative technology and novel product launches, companies in the safety needles market across the world are actively engaged in the process of mergers and acquisitions in order to strengthen their product portfolio and cement their position in the market. Top market players are adopting the strategy of mergers and acquisitions to enhance their brand value and to develop more effective and efficient products while meeting the global standards for safety and efficiency. This will help companies increase their market share and expand their consumer base in uncharted territories.

Strategic acquisition case study – Boston Scientific and Xlumena Inc.

In 2015, Boston Scientific reached an agreement announcing the acquisition of Xlumena, a company that manufactures minimally invasive devices to carry out endoscopic ultrasound (EUS) enabled transluminal drainage of specific target areas in the gastrointestinal tract. According to the terms and conditions of the deal, besides an initial upfront payment, Boston Scientific shall also pay an additional amount to Xlumena once the FDA gives clearance to Xlumena’s HOT AXIOS device. In addition, sales milestones as per volume sales achieved in 2018 are also a part of the deal. The advanced HOT AXIOS Stent and Delivery System integrates cautery in the AXIOS stent that has been approved by the FDA. This strategic acquisition will help Boston Scientific establish its stronghold in the EUS segment.

Worldwide safety legislations regarding safety needles

In the year 1991, the Blood Borne Pathogen standard was established in the U.S. 1999 was a landmark year as anti-needlestick legislation was implemented in California, U.S. In the year 2000, Federal Anti-Needlestick legislation was passed in the U.S. In 2005, order 827/2005 was set by the Ministry of Health in Spain. In 2007, the National Health Service Reference Guide was implemented in the U.K. In the same year, Sharp Injury Protection was legislated in Germany. In 2008, Sharp Injury Protection was legislated in Canada. In the year 2010, a legislation was passed in Brazil regarding needlestick injuries. In 2011, the Amendment to Medical Care Act was passed in Taiwan that takes into account needlestick injuries. The year 2013 was the deadline for Sharps Legislation implementation in the European Union. More countries are expected to follow soon and enact legislations regarding needlestick injuries and their prevention. Government enforcement to use safety needles in various countries likely to give a boost to the global safety needles market

In order to avoid hospital acquired diseases such as HIV, Hepatitis C and Hepatitis B etc., governments in various countries are implementing stringent regulations as mentioned above. Needlestick injuries sustained from contaminated needles can result in infections from various harmful blood borne diseases. As per a report by the Program for Appropriate Technology in Health (PATH) published in 2005, due to the reuse of contaminated needles, 2 Mn Hepatitis C infections, 20 Mn Hepatitis B infections and 250,000 HIV infections are caused annually. Various government supported norms such as Needlestick Safety and Prevention Act, Needles Exchange Program and implementation of OSHA’s blood borne pathogens standards are increasing awareness among the population about diseases caused by using contaminated needles, and this factor is likely to fuel the demand for better quality safety needles.

【レポートの目次】

Table Of Content

1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

3. Global Safety Needles Market Analysis Scenario

3.1. Market Volume Analysis

3.2. Pricing Analysis

3.2.1. Price Projections Per Region

3.3. Market Size (US$ Mn) and Forecast

3.3.1. Market Size and Y-o-Y Growth

3.3.2. Absolute $ Opportunity

3.4. Market Overview

3.4.1. Value Chain

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Global Trend

4.6. Worldwide Safety Legislation

4.7. Key Developments – BD Staked Needle Prefilled Syringes Development

4.8.Product Comparison: Challenges faced in using Safety Needles

4.9.NHS Evaluation: Safety-engineered Hypodermic Needles

5. Global Safety Needles Market Analysis and Forecasts, By Product Type

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Product Type

5.3. Y-o-Y Growth Projections By Product Type

5.4.Market Value and Volume Forecast By Product Type, 2017–2027

5.4.1. Fine Aspirating Needles

5.4.2. Biopsy Needles

5.4.3. Hypodermic Needles

5.4.4. Pen Needles

5.4.5. Suture Needles

5.4.6. IV Catheter Needles

5.4.7. Huber Needles

5.4.8. Blood Collection Needle

5.4.9. Spinal Anesthesia and epidural Needle

5.4.10. Prefilled Needle

5.4.11. A.V. Fistula Needle

5.4.12. Cannula Needles

5.5. Market Attractiveness By Product Type

6. Global Safety Needles Market Analysis and Forecasts, By Application

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Application

6.3. Y-o-Y Growth Projections By Application

6.4. Market Value and Volume Forecast By Application, 2017–2027

6.4.1. Sample Collection

6.4.2. Drug Delivery

6.4.5. Injection

6.5. Market Attractiveness By Application

7. Global Safety Needles Market Analysis and Forecasts, By Distribution Channel

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By Distribution Channel

7.3. Y-o-Y Growth Projections By Distribution Channel

7.4. Market Value and Volume Forecast By Distribution Channel, 2017–2027

7.4.1. Hospital Pharmacy

7.4.2. Private Clinics

7.4.3. Retail Pharmacies and Drug Stores

7.4.4. E- Commerce

7.5. Market Attractiveness By Distribution Channel

8. Global Safety Needles Market Analysis and Forecasts, By Region

8.1. Basis Point Share (BPS) Analysis By Region

8.2. Y-o-Y Growth Projections By Region

8.3. Market Value and Volume Forecast By Region

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. APEJ

8.3.6. Japan

8.3.7. MEA

8.4. Market Attractiveness By Region

9. North America Safety Needles Market Analysis and Forecast

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.1.3. Key Regulations

9.2. Market Value and Volume Forecast By Product Type, 2017–2027

9.2.1. Fine Aspirating Needles

9.2.2. Biopsy Needles

9.2.3. Hypodermic Needles

9.2.4. Pen Needles

9.2.5. Suture Needles

9.2.6. IV Catheter Needles

9.2.7. Huber Needles

9.2.8. Blood Collection Needle

9.2.9. Spinal Anesthesia and epidural Needle

9.2.10. Prefilled Needle

9.2.11. A.V. Fistula Needle

9.2.12. Cannula Needles

9.3. Market Value and Volume Forecast By Application, 2017–2027

9.3.1. Sample Collection

9.3.2. Drug Delivery

9.3.3. Injection

9.4. Market Value and Volume Forecast By Distribution Channel, 2017–2027

9.4.1. Hospital Pharmacy

9.4.2. Private Clinics

9.4.3. Retail Pharmacies and Drug Stores

9.4.4. E- Commerce

9.5.Market Value and Volume Forecast By Country, 2017–2027

9.5.1. US

9.5.2. Canada

9.6. Market Attractiveness Analysis

9.6.1. By Product Type

9.6.2. By Application

9.6.3. By Distribution Channel

9.6.4. By Country

9.7. Drivers and Restraints: Impact Analysis

10. Latin America Safety Needles Market Analysis and Forecast

10.1.Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.1.3. Key Regulations

10.2.Market Value and Volume Forecast By Product Type, 2017–2027

10.2.1. Fine Aspirating Needles

10.2.2. Biopsy Needles

10.2.3. Hypodermic Needles

10.2.4. Pen Needles

10.2.5. Suture Needles

10.2.6. IV Catheter Needles

10.2.7. Huber Needles

10.2.8. Blood Collection Needle

10.2.9. Spinal Anesthesia and epidural Needle

10.2.10. Prefilled Needle

10.2.11. A.V. Fistula Needle

10.2.12. Cannula Needles

10.3.Market Value and Volume Forecast By Application, 2017–2027

10.3.1. Sample Collection

10.3.2. Drug Delivery

10.3.3. Injection

10.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacy

10.4.2. Private Clinics

10.4.3. Retail Pharmacies and Drug Stores

10.4.4. E- Commerce

10.5.Market Value and Volume Forecast By Country, 2017–2027

10.5.1. Argentina

10.5.2. Brazil

10.5.3. Mexico

10.5.4. Rest of Latin America

10.6.Market Attractiveness Analysis

10.6.1. By Product Type

10.6.2. By Application

10.6.3. By Distribution Channel

10.6.4. By Country

10.7. Drivers and Restraints: Impact Analysis

11. Western Europe Safety Needles Market Analysis and Forecast

11.1.Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country

11.1.2. Y-o-Y Growth Projections By Country

11.1.3. Key Regulations

11.2.Market Value and Volume Forecast By Product Type, 2017–2027

11.2.1. Fine Aspirating Needles

11.2.2. Biopsy Needles

11.2.3. Hypodermic Needles

11.2.4. Pen Needles

11.2.5. Suture Needles

11.2.6. IV Catheter Needles

11.2.7. Huber Needles

11.2.8. Blood Collection Needle

11.2.9. Spinal Anesthesia and epidural Needle

11.2.10. Prefilled Needle

11.2.11. A.V. Fistula Needle

11.2.12. Cannula Needles

11.3.Market Value and Volume Forecast By Application, 2017–2027

11.3.1. Sample Collection

11.3.2. Drug Delivery

11.3.3. Injection

11.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacy

11.4.2. Private Clinics

11.4.3. Retail Pharmacies and Drug Stores

11.4.4. E- Commerce

11.5.Market Value and VolumeForecast By Country, 2017–2027

11.5.1. UK

11.5.2. France

11.5.3. Germany

11.5.4. Italy

11.5.5. Spain

11.5.6. Nordic

11.5.7. Benelux

11.5.8. Rest of Western Europe

11.6.Market Attractiveness Analysis

11.6.1. By Product Type

11.6.2. By Application

11.6.3. By Distribution Channel

11.6.4. By Country

11.7. Drivers and Restraints: Impact Analysis

12. Eastern Europe Safety Needles Market Analysis and Forecast

12.1.Introduction

12.1.1. Basis Point Share (BPS) Analysis By Country

12.1.2. Y-o-Y Growth Projections By Country

12.1.3. Key Regulations

12.2.Market Value and Volume Forecast By Product Type, 2017–2027

12.2.1. Fine Aspirating Needles

12.2.2. Biopsy Needles

12.2.3. Hypodermic Needles

12.2.4. Pen Needles

12.2.5. Suture Needles

12.2.6. IV Catheter Needles

12.2.7. Huber Needles

12.2.8. Blood Collection Needle

12.2.9. Spinal Anesthesia and epidural Needle

12.2.10. Prefilled Needle

12.2.11. A.V. Fistula Needle

12.2.12. Cannula Needles

12.3.Market Value and Volume Forecast By Application, 2017–2027

12.3.1. Sample Collection

12.3.2. Drug Delivery

12.3.3. Injection

12.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacy

12.4.2. Private Clinics

12.4.3. Retail Pharmacies and Drug Stores

12.4.4. E- Commerce

12.5.Market Value and Volume Forecast By Country, 2017–2027

12.5.1. Russia

12.5.2. Poland

12.5.3. Rest of Eastern Europe

12.6.Market Attractiveness Analysis

12.6.1. By Product Type

12.6.2. By Application

12.6.3. By Distribution Channel

12.6.4. By Country

12.7. Drivers and Restraints: Impact Analysis

13. APEJ Safety Needles Market Analysis and Forecast

13.1.Introduction

13.1.1. Basis Point Share (BPS) Analysis By Country

13.1.2. Y-o-Y Growth Projections By Country

13.1.3. Key Regulations

13.2.Market Value and Volume Forecast By Product Type, 2017–2027

13.2.1. Fine Aspirating Needles

13.2.2. Biopsy Needles

13.2.3. Hypodermic Needles

13.2.4. Pen Needles

13.2.5. Suture Needles

13.2.6. IV Catheter Needles

13.2.7. Huber Needles

13.2.8. Blood Collection Needle

13.2.9. Spinal Anesthesia and epidural Needle

13.2.10. Prefilled Needle

13.2.11. A.V. Fistula Needle

13.2.12. Cannula Needles

13.3.Market Value and Volume Forecast By Application, 2017–2027

13.3.1. Sample Collection

13.3.2. Drug Delivery

13.3.3. Injection

13.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacy

13.4.2. Private Clinics

13.4.3. Retail Pharmacies and Drug Stores

13.4.4. E- Commerce

13.5.Market Value and Volume Forecast By Country, 2017–2027

13.5.1. China

13.5.2. India

13.5.3. Australia & New Zealand

13.5.4. ASEAN

13.5.5. Rest of APEJ

13.6.Market Attractiveness Analysis

13.6.1. By Product Type

13.6.2. By Application

13.6.3. By Distribution Channel

13.6.4. By Country

13.7. Drivers and Restraints: Impact Analysis

14. Japan Safety Needles Market Analysis and Forecast

14.1.Introduction

14.1.1. Basis Point Share (BPS) Analysis By Country

14.1.2. Y-o-Y Growth Projections By Country

14.1.3. Key Regulations

14.2.Market Value and Volume Forecast By Product Type, 2017–2027

14.2.1. Fine Aspirating Needles

14.2.2. Biopsy Needles

14.2.3. Hypodermic Needles

14.2.4. Pen Needles

14.2.5. Suture Needles

14.2.6. IV Catheter Needles

14.2.7. Huber Needles

14.2.8. Blood Collection Needle

14.2.9. Spinal Anesthesia and epidural Needle

14.2.10. Prefilled Needle

14.2.11. A.V. Fistula Needle

14.2.12. Cannula Needles

14.3.Market Value and Volume Forecast By Application, 2017–2027

14.3.1. Sample Collection

14.3.2. Drug Delivery

14.3.3. Injection

14.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacy

14.4.2. Private Clinics

14.4.3. Retail Pharmacies and Drug Stores

14.4.4. E- Commerce

14.5.Market Attractiveness Analysis

14.5.1. By Product Type

14.5.2. By Application

14.5.3. By Distribution Channel

14.6. Drivers and Restraints: Impact Analysis

15. MEA Safety Needles Market Analysis and Forecast

15.1.Introduction

15.1.1. Basis Point Share (BPS) Analysis By Country

15.1.2. Y-o-Y Growth Projections By Country

15.1.3. Key Regulations

15.2.Market Value and Volume Forecast By Product Type, 2017–2027

15.2.1. Fine Aspirating Needles

15.2.2. Biopsy Needles

15.2.3. Hypodermic Needles

15.2.4. Pen Needles

15.2.5. Suture Needles

15.2.6. IV Catheter Needles

15.2.7. Huber Needles

15.2.8. Blood Collection Needle

15.2.9. Spinal Anesthesia and epidural Needle

15.2.10. Prefilled Needle

15.2.11. A.V. Fistula Needle

15.2.12. Cannula Needles

15.3.Market Value and Volume Forecast By Application, 2017–2027

15.3.1. Sample Collection

15.3.2. Drug Delivery

15.3.3. Injection

15.4.Market Value and Volume Forecast By Distribution Channel, 2017–2027

15.4.1. Hospital Pharmacy

15.4.2. Private Clinics

15.4.3. Retail Pharmacies and Drug Stores

15.4.4. E- Commerce

15.5.Market Value and Volume Forecast By Country, 2017–2027

15.5.1. GCC Countries

15.5.2. South Africa

15.5.3. North Africa

15.5.4. Rest of MEA

15.6.Market Attractiveness Analysis

15.6.1. By Product Type

15.6.2. By Application

15.6.3. By Distribution Channel

15.6.4. By Country

15.7. Drivers and Restraints: Impact Analysis

16. Competition Landscape

16.1. Competition Dashboard

16.2. Market Share Analysis By Company (2016)

16.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

16.3.1. Medtronic

16.3.2. Becton, Dickinson and Company

16.3.3. Boston Scientific Corporation

16.3.4. Smith Medical

16.3.5. Argon Medical Devices, Inc.

16.3.6. Novo Nordisk A/S

16.3.7. Terumo Corporation

16.3.8. NIPRO Medical Corporation

16.3.9. B. Braun Melsungen AG

17. Assumptions and Acronyms Used

18. Research Methodology



★調査レポート[安全針の世界市場] (コード:DATA70609028)販売に関する免責事項を必ずご確認ください。
★調査レポート[安全針の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆